微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.61% | -22.97% | -73.08% | 52/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 5.98% | -28.55% | 5.84% | 49/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 5.65% | -32.17% | 31.4% | 50/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.3% | -32.28% | 105.74% | 37/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.09% | -27.18% | -75.03% | 43/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 8.37% | -6.69% | 0.48% | 40/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 8.33% | -2% | 31.18% | 29/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 6.35% | 3.25% | 121.25% | 21/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.87% | -13.55% | -68% | 30/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 8.97% | -7.91% | 5.53% | 43/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.5% | 3.79% | 38.21% | 39/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.15% | -10.87% | 85.24% | 33/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.32% | 29.69% | -65.91% | 36/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 9.74% | 17.78% | 18.93% | 67/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.19% | -13.88% | 18.7% | 67/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.9% | 16.36% | 169.53% | 53/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.56% | -21.95% | -69.04% | 61/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 8.27% | 81.36% | -13.04% | 91/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 9.51% | 91.35% | 60.37% | 62/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 5.93% | 121.27% | 80.79% | 73/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.28% | 310% | -28.07% | 50/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 4.56% | 670% | -8.25% | 110/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 4.97% | -77.04% | 85.45% | 69/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 2.68% | 119.67% | 235% | 91/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.8% | -94.1% | 200% | 60/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -0.8% | 59.6% | -103.7% | 110/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 21.65% | 374.78% | 1674.59% | 10/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.22% | 35.56% | -91% | 66/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 13.55% | 1475.58% | 784.34% | 1/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | -1.98% | 52.4% | -143.42% | 100/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.56% | 1100% | 406.67% | 42/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 0.9% | -41.94% | 4.65% | 52/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.86% | -36.3% | 120.67% | 43/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | -4.16% | -182.99% | -1194.74% | 99/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 0.38% | -91.42% | -75.48% | 47/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 1.55% | -19.27% | 14.81% | 50/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.35% | 2.27% | 191.84% | 35/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | -1.47% | -122.04% | -133.18% | 75/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 4.43% | -33.28% | 130.73% | 31/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 1.92% | -53.06% | 45.45% | 43/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 1.32% | -51.29% | -80.21% | 25/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |